Our Blog

Patient Story

“The entire experience of participating in the clinical trial has been exceptional. The team at Re:Cognition Health genuinely prioritises the wellbeing of their patients. Their understanding and […]

Hearing Loss and Dementia: Understanding the Link and Why Early Intervention Matters

Dr Steve Allder, Consultant Neurologist at Re:Cognition Health, recently shared his insights with Medical News Today following the release of a significant new study that shines a […]

A Pivotal Time in Alzheimer’s Treatment: Slowing the Disease Before It Progresses

Dr Emer MacSweeney, CEO of Re:Cognition Health, has shared with Healthcare World why recent developments in Alzheimer’s treatment mark a major breakthrough in neurology. Alzheimer’s disease, long […]

New Alzheimer’s Medications

Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health shared her excitement with the Daily Express about the groundbreaking new Alzheimer’s drugs that are now available […]

Re:Cognition Health Brings Groundbreaking Alzheimer’s Treatment Kisunla™ to Private Patients

Re:Cognition Health is proud to announce the launch of Kisunla™ (donanemab), a revolutionary Alzheimer’s treatment, for private patients at our specialist clinics. This follows the success of […]